- Home
- CRVS vs INV Comparison
CRVS vs INV Comparison
Compare CRVS & INV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- INV
- Stock Information
- Founded
- CRVS 2014
- INV 2015
- Country
- CRVS United States
- INV United States
- Employees
- CRVS N/A
- INV N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- INV
- Sector
- CRVS Health Care
- INV
- Exchange
- CRVS Nasdaq
- INV NYSE
- Market Cap
- CRVS 206.5M
- INV 173.3M
- IPO Year
- CRVS 2016
- INV N/A
- Fundamental
- Price
- CRVS $3.61
- INV $4.86
- Analyst Decision
- CRVS Strong Buy
- INV Strong Buy
- Analyst Count
- CRVS 3
- INV 2
- Target Price
- CRVS $16.33
- INV $14.00
- AVG Volume (30 Days)
- CRVS 1.6M
- INV 58.5K
- Earning Date
- CRVS 05-08-2025
- INV 05-15-2025
- Dividend Yield
- CRVS N/A
- INV N/A
- EPS Growth
- CRVS N/A
- INV N/A
- EPS
- CRVS N/A
- INV N/A
- Revenue
- CRVS N/A
- INV $1,220,000.00
- Revenue This Year
- CRVS N/A
- INV $1,336.39
- Revenue Next Year
- CRVS N/A
- INV $204.86
- P/E Ratio
- CRVS N/A
- INV N/A
- Revenue Growth
- CRVS N/A
- INV 18.27
- 52 Week Low
- CRVS $1.75
- INV $3.00
- 52 Week High
- CRVS $10.00
- INV $18.75
- Technical
- Relative Strength Index (RSI)
- CRVS 50.22
- INV N/A
- Support Level
- CRVS $3.46
- INV N/A
- Resistance Level
- CRVS $4.53
- INV N/A
- Average True Range (ATR)
- CRVS 0.28
- INV 0.00
- MACD
- CRVS 0.02
- INV 0.00
- Stochastic Oscillator
- CRVS 32.60
- INV 0.00
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.